Navigation Links
Richter Rubber Technology Selects Vystar Corporation's Vytex® Natural Rubber Latex (NRL) for Products to Launch This Year

ATLANTA, Nov. 16, 2010 /PRNewswire/ -- Vystar® Corporation (OTC Bulletin Board: VYST), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex, announces that condom manufacturer, Richter Rubber Technology (RRT), Sdn. Bhd., Malaysia, will launch two new product lines: Vytex NRL condoms and ultrasound probe covers.



The line of Viva condoms and probe covers made with Vytex NRL is expected to be commercially available by the end of the year through Richter Rubber's established distribution channels and retail outlets.  Richter Rubber will announce the launch and showcase the new line of products at MEDICA 2010, The 42nd World Forum for Medicine/ International Trade Fair, in Dusseldorf, Germany from November 17 to 20.  MEDICA is the world's largest medical trade show, attracting over 138,000 attendees in 2009.

With over 85 years of manufacturing expertise, Richter Rubber markets its own "Viva" line of condoms throughout Europe and provides contract manufacturing for those manufacturers seeking preferred German quality combined with the competitive advantages of Malaysian manufacturing.  The Vytex NRL probe covers, which are structurally identical to condoms, are designed to protect both the patient and the equipment when ultrasound procedures are being performed.

"Our condoms and probe covers made with Vytex NRL will provide our customers with the best protective material, natural rubber latex, enhanced by the performance benefits of Vytex NRL, with virtually undetectable levels of antigenic proteins." says Klaus Richter, President, Richter Rubber Technology.  Mr. Klaus continues: "The condom and probe cover markets are highly competitive and require continual innovation to retain and grow share.  We are confident that Vytex NRL will provide us with this competitive advantage."

William Doyle, Vystar's President and CEO, says "We are pleased to see the adoption of Vytex NRL and look forward to working with Richter Rubber on their new lines of condoms and ultrasound probe covers. Richter Rubber represents high quality and innovation from a long tenured condom manufacturer in the industry. Vytex NRL is well positioned for the condom market where natural rubber latex remains the consumer's material of choice.  With Vytex NRL there is no trade off for fit, comfort, and sensitivity in condoms."

About Richter Rubber Technology, Sdn. Bhd.

Richter Rubber Technology (RRT), headquartered in Kedah Darul Aman, Malaysia, is a pioneer in the condom industry with over 85 years in the manufacturing of own-brand and third party branded condoms.  Richter Rubber Technology was the developer of the first automatic latex condom dipping line in Germany.  Its own brand, "Viva", is a well known brand sold throughout Europe and is known for its specialty line to meet the growing demand of consumers worldwide. Richter Rubber production facilities are ISO-9001-2000 Certified and RRT holds CE (Europe) Certification, EN (Europe), ISO (International), and U.S. FDA 510(k) market clearance for their condom line.  For more information, visit

About Vystar Corporation

Based in Duluth, GA, Vystar ® Corporation (OTC Bulletin Board: VYST) is the exclusive creator of Vytex Natural Rubber Latex (Vytex NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of antigenic proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, balloons, surgical and exam gloves, other medical devices and natural rubber latex foam mattresses, pillows and sponges.  For more information, visit

Forward-looking Statements: Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.  Actual results may differ materially from those included in these statements due to a variety of factors.  More information about these factors is contained in Vystar's filings with the Securities and Exchange Commission.

SOURCE Vystar Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings
4. Kent Elastomer Adds Vytex® Low Protein Natural Rubber Latex (NRL) to Product Offering
5. Judge, Jury = Status Quo: Astonishment as Medical Panel Rubber Stamps its Own Controversial Guidelines
6. BioWa Announces License of POTELLIGENT® Technology to Agensys
7. HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology
8. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
9. Alma Lasers Introduces Soprano(XLi) Next Generation Diode Laser Technology
10. Frost & Sullivan Recognizes Merge Healthcares Clinical Imaging Management Solution as Game Changing Technology
11. Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting on November 11-13, 2010
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 Research and ... the "Membranes Market - Global Forecast to 2020" ... Asia-Pacific , accounting for 37.21% of the total ... Asia-Pacific region is projected to growth ... growth has been attributed primarily to the fast growing ...
(Date:11/25/2015)... 2015 --> ... Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, welches ... innehaben, an Enyo Pharma vergeben haben. Im ... gerufenen und von Edelris gemeinsam mit seinen Partnern Inserm ... für HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, ...
(Date:11/25/2015)... DUBLIN , November 25, 2015 ... has announced the addition of the  ... 2015-2019"  report to their offering.  ... announced the addition of the  "Global ...  report to their offering.  ...
Breaking Medicine Technology:
(Date:11/24/2015)... , ... November 24, 2015 , ... DMG Productions announced ... Begley Jr., airing first quarter 2016 via Discovery Channel. Dates and show times TBA. ... Province, and is in the business of producing and supplying medical marijuana pursuant to ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... LENR HHT Bolier Reactor System. Brillouin is the developer of renewable energy technologies ... low energy nuclear reactions (“LENR”), announced today that its WET™ and HHT™ Boiler ...
(Date:11/24/2015)... ... 2015 , ... American Family Care (AFC), the nation’s leading provider of urgent ... located in Metro Atlanta’s North Point Mall. The clinic is designed to test the ... is scheduled to operate through Dec. 24. , Holiday Pop-Up Clinic , Official Opening ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... been designated an Aetna Institute of Quality® Bariatric Surgery Facility for treating individuals ... and cost of health care services available to its members to help them ...
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL LEADERSHIP: ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November 24, ... patients and their families, shaped my desire to improve the system of care. I ...
Breaking Medicine News(10 mins):